All data are based on the daily closing price as of July 18, 2025
t

Tsumura &

4540.TSE
24.45 USD
0.04
+0.16%

Overview

Last close
24.45 usd
Market cap
1.84B usd
52 week high
33.80 usd
52 week low
17.64 usd
Target price
27.87 usd

Valuation

P/E
8.5034
Forward P/E
11.4811
Price/Sales
1.5125
Price/Book Value
0.9102
Enterprise Value
1.82B usd
EV/Revenue
1.4945
EV/EBITDA
4.7275

Key financials

Revenue TTM
1.22B usd
Gross Profit TTM
608.64M usd
EBITDA TTM
344.66M usd
Earnings per Share
2.87 usd
Dividend
0.91 usd
Total assets
3.11B usd
Net debt
-19.39M usd

About

Tsumura & Co. manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally. The company offers Kampo extract intermediates, granular and prescription Kampo formulations, over-the-counter Kampo medicine, other medications, and herbal bath salts. It offers its products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation, hemorrhoid, body aches, cold, cough, nasal/throat inflammation, children's sickness, stress, and urinary problems. Tsumura & Co. was founded in 1893 and is headquartered in Tokyo, Japan.
  • Symbol
    4540.TSE
  • Exchange
    TSE
  • Isin
    JP3535800001
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Terukazu Kato
  • Headquarter
    Tokyo
  • Web site
    https://www.tsumura.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top